Eris Lifesciences Ltd.

NSE: ERIS · Healthcare

₹1,236.30

as of 28 Sep 2026

AI verdict · 28 Sep 2026

Bearish 58% confidence

Severe 15-point underperformance vs NIFTY over 12 months and missing fundamentals prevent confidence in oversold technicals; next earnings…

Strongest bull point

RSI at 33 and price at 52-week low with below-average volume suggest capitulation exhaustion; reversal toward EMA-20 (₹1,305, +3.7%) is plausible if support holds and volume confirms.

Strongest bear point

15-percentage-point relative underperformance vs NIFTY indicates stock-specific distress, not temporary sector headwinds; quiet news post-results raises risk of hidden earnings deterioration.

Technical Forecast · next 10 trading days

Expected

₹1,330.22 +7.6%

Range

₹1,330.21 – ₹1,331.87

Technical Forecast Fundamental Debate

Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.

Every call on ERIS, misses included

Bearish 28 Sep 2026 → now Scores 28 Oct 2026

₹1,236.30 → ₹1,236.30 0.0%

Our accuracy

Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.

How we score →

More Healthcare